* Projects ongoing phase 1b study evaluating omadacycline in
treatment of uuti will report data in q4 2016
The post BRIEF-Paratek accelerates timing for projected reporting of results from early-stage UTI study appeared first on NASDAQ.
BRIEF-Paratek accelerates timing for projected reporting of results from early-stage UTI study
